On the afternoon of January 28, 2026, Sacco System, an Italian century-old biotechnology enterprise, held the grand opening ceremony for its China subsidiary in Shanghai. Themed “A New Century: The Sacco System Chapter in China,” the event blended Italian scientific spirit with traditional Eastern rituals, welcoming distinguished guests from government bodies, industry associations, research institutions, partners, and the media. The ceremony featured traditional inauguration rituals such as the “Eye-Dotting” and ribbon-cutting, led by Viola Verga one of the fifth-generation representatives of the Verga family.
Consulate General of Italy in Shanghai, Italian Trade Agency and Italian Chamber of Commerce in China (CCIC) participated the event alongside key Chinese guests. These acts symbolized the profound integration of Eastern and Western technology and culture. The event also premiered the Group’s 10th-anniversary brand renewal film, showcasing a century of heritage and a commitment to innovation.
Sacco System is an international biotechnology group specializing in the research, development, and production of natural and innovative biotechnological solutions for the food, nutraceutical, pharmaceutical, and agro-veterinary sectors. As a “microbial innovator,” the Group is dedicated to enhancing the lives of humans, animals, and plants through the research and development of microorganisms. Its product portfolio includes lactic ferments, probiotics, postbiotics, enzymes, and various functional ingredients, all aimed at promoting health and well-being. For over 150 years, Sacco System has adhered to its ultimate mission of “Nurturing the World,” providing comprehensive support to customers through innovative biotechnology. Today, the Group serves more than 110 countries and regions worldwide, supported by over 70 R&D specialists, an extensive network of agents, 8 production facilities, and 4 pilot laboratories, delivering holistic and personalized services to the global biotech market. Passed down through generations, Sacco System maintains a strong family ethos and deep local roots, now complemented by a global vision that positions it as a benchmark in sustainable development through microbial innovation.
Sacco System’s strategic expansion into the Asia-Pacific region is built upon its century-long heritage. The Group’s core entities were established over time: Caglificio Clerici in 1872, Sacco in 1934, and CSL in 1948, which were integrated in 2016 to form the Sacco System Group. With a solid technological and industrial foundation established in Europe, the Group turned its focus to the vibrant Asia-Pacific market in the 2010s. The first regional subsidiary was established in Singapore in 2018, serving as a regional operational and R&D hub. Since then, the Group has steadily advanced its localization strategy, entering Japan in 2020, Australia in 2023, and finally establishing its presence in China in 2025. The launch of the China subsidiary not only marks the completion of Sacco System’s “R&D-Production-Market” strategic framework in the Asia-Pacific region but also signifies the deep integration of its century-old microbial technology into one of the world’s most dynamic and promising hubs for biological innovation. The China subsidiary will serve as a key engine within the Group’s Asia-Pacific innovation network, undertaking critical missions such as localizing cutting-edge technologies, developing cross-market solutions, and fostering an open innovation ecosystem.
“China is not only a strategic market but also a vital ground for advancing our mission of ‘Nurturing the World’,” stated the representative of Sacco System’s China entity, Siyike. “The name ‘Siyike’ embodies our commitment to this cause—‘Si’ (思) represents contemplating the essence of life, ‘Yi’ (益) signifies contributing to a healthier future, and ‘Ke’ (可) stands for sustainable development. This aligns seamlessly with the Group’s ultimate goal of ‘Nurturing the World’.”
In China, Siyike will serve as the Group’s core platform for realizing the vision of ‘Nurturing the World’. Through a “dual-engine innovation” model, it will integrate century-old technological expertise with local wisdom by:
Establishing R&D cooperation platforms: Partnering with Chinese research institutions to work on current and next-generation functional probiotics and fermentation solutions tailored to Eastern dietary habits and health needs.
Exploring Integrated Microbial Research: Combining Italian fermentation science with traditional Chinese health wisdom to develop culturally adaptive health products.
“We bring not only microbial strains and technologies but also a long-term commitment to life,” emphasized the representative. “From a century of dedication in Italian laboratories to taking root in China under the name ‘Siyike,’ we believe that every microbial innovation can become a seed that nourishes the symbiotic system of humans, animals, and plants. Here in China, ‘Siyike’ will carry forward the mission of ‘Nurturing the World,’ working hand in hand with local partners to cultivate a healthier and more sustainable future.”
